Mesoblast adult human mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesoblast adult human mesenchymal stem cells, covering 2022-01-31 to 2022-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD) [Phase 2]